Article | February 22, 2023

Addressing The Challenges Of Residual Host Cell DNA Contamination

By Marwan Alsarraj

Scientist Laboratory sample pipette GettyImages-1354172647

With a growing number of exciting advancements in the cell and gene therapy sector, the challenges when manufacturing therapeutics of this type reliably is becoming ever more apparent. One persistent problem is residual host cell DNA contamination.

Droplet Digital™ PCR (ddPCR™) technology offers absolute quantification, eliminating the need for standard curves. It can provide the sensitive, specific, reproducible results needed to meet regulatory standards with confidence. Explore why purification is so important, the limits of common molecular methods, and how ddPCR™ could form the future of molecular detection.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene